Detailed Narrative
Execution Momentum and Revenue Guidance
Zen Technologies achieved approximately ₹500 crores in revenue during H1 FY25, representing over 50% of its annual guidance of ₹900 crores. Despite this strong start, management remains cautious, citing a small miss in the previous year's targets. They expect to 'definitely exceed' the ₹900 crore mark but are refraining from officially raising the target to ₹1,000 crores yet. The company maintains a long-term growth outlook of a 50% average CAGR over the next three years.
Order Pipeline and Future Inflows
The current order pipeline is valued at ₹3,500 crores, with approximately ₹2,000 crores already submitted in bids. Management expects a significant conversion of this pipeline in the second half of the year, targeting ₹1,200 crores in fresh order inflows by March 2025. These orders are expected to be a mix of simulators and anti-drone systems, with a historical split of roughly 60-40.
Strategic Pivot to the US Market
A major theme of the call was the 'Make in America' strategy. Zen plans to establish a manufacturing facility in the US with a capex of less than $10 million (₹80 crores) to comply with 51% local content requirements. Management believes their simulator technology is 'two generations ahead' of US competitors and expects large-scale orders from the Americas to materialize by FY2027, potentially contributing 10-50% of total revenue in the long term.
Capital Allocation and M&A Strategy
With ₹1,100 crores in cash, the company has a clear deployment plan: ₹400 crores for strategic acquisitions, ₹100 crores for capex, and ₹300-400 crores for working capital to support rapid growth. They are looking at acquisition targets in the ₹100-300 crore range, both in India and overseas, specifically to expand their capabilities into Navy and Air Force simulation segments.
Margin Sustainability and Working Capital
While gross margins saw a temporary dip to 50% due to product mix and R&D spending, operational EBITDA margins remained healthy at 36.80%. Management is confident in maintaining a 35% EBITDA and 25% PAT margin profile. Working capital remains a focus area, as receivables spiked to ₹411 crores (200 days) in H1; the CFO expects this to normalize to 160-170 days by the end of the financial year as realizations improve in Q3 and Q4.